Quarterly report · Q3
9627.TEDINET S100T2A7
Period2023-05-01 → 2024-01-31
Filed2024-03-15
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥296.4bn | 2023-05-01 → 2024-01-31 | Cons. | Net sales |
| Revenue | ¥358.7bn | 2022-05-01 → 2023-04-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥263.9bn | 2022-05-01 → 2023-01-31 | Cons. | Net sales |
| Operating income | ¥14.3bn | 2023-05-01 → 2024-01-31 | Cons. | Operating income |
| Operating income | ¥11.7bn | 2022-05-01 → 2023-01-31 | Cons. | Operating income |
| Ordinary income | ¥15.1bn | 2023-05-01 → 2024-01-31 | Cons. | Ordinary income |
| Ordinary income | ¥17.1bn | 2022-05-01 → 2023-04-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥12.4bn | 2022-05-01 → 2023-01-31 | Cons. | Ordinary income |
| Profit before tax | ¥15.0bn | 2023-05-01 → 2024-01-31 | Cons. | Income before income taxes |
| Profit before tax | ¥12.1bn | 2022-05-01 → 2023-01-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥8.7bn | 2023-05-01 → 2024-01-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥9.2bn | 2022-05-01 → 2023-04-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥6.6bn | 2022-05-01 → 2023-01-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥8.7bn | 2023-05-01 → 2024-01-31 | Cons. | Profit loss |
| Net income | ¥6.6bn | 2022-05-01 → 2023-01-31 | Cons. | Profit loss |
| Total assets | ¥243.7bn | at 2024-01-31 | Cons. | Assets |
| Total assets | ¥231.8bn | at 2023-04-30 | Cons. | Assets |
| Total assets | ¥229.6bn | at 2023-01-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥110.4bn | at 2024-01-31 | Cons. | Liabilities |
| Total liabilities | ¥105.2bn | at 2023-04-30 | Cons. | Liabilities |
| Net assets / equity | ¥133.3bn | at 2024-01-31 | Cons. | Net assets |
| Net assets / equity | ¥126.5bn | at 2023-04-30 | Cons. | Net assets |
| Net assets / equity | ¥123.7bn | at 2023-01-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥50.1bn | at 2024-01-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥46.8bn | at 2023-04-30 | Cons. | Cash and deposits |
| EPS (basic) | ¥248.51 | 2023-05-01 → 2024-01-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥98.85 | 2023-11-01 → 2024-01-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥262.87 | 2022-05-01 → 2023-04-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥188.7 | 2022-05-01 → 2023-01-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥80.4 | 2022-11-01 → 2023-01-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 54.7% | at 2024-01-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.6% | at 2023-04-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 53.9% | at 2023-01-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 34
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2023-05-01 → 2024-01-31 | ¥8.5bn |
| Otherother segments | revenue external | 2023-05-01 → 2024-01-31 | ¥8.4bn |
| Otherother segments | revenue intersegment | 2023-05-01 → 2024-01-31 | ¥37m |
| Otherother segments | segment ordinary income | 2023-05-01 → 2024-01-31 | −¥80m |
| Reconciling Itemsreconciling | revenue | 2023-05-01 → 2024-01-31 | −¥37m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-05-01 → 2024-01-31 | −¥37m |
| Reconciling Itemsreconciling | segment ordinary income | 2023-05-01 → 2024-01-31 | −¥6.8bn |
| jpcrp040300-q3r_E04896-000Dispensing Pharmacyreportable segment | revenue | 2023-05-01 → 2024-01-31 | ¥265.0bn |
| jpcrp040300-q3r_E04896-000Dispensing Pharmacyreportable segment | revenue external | 2023-05-01 → 2024-01-31 | ¥265.0bn |
| jpcrp040300-q3r_E04896-000Dispensing Pharmacyreportable segment | segment ordinary income | 2023-05-01 → 2024-01-31 | ¥19.7bn |
| jpcrp040300-q3r_E04896-000Drug And Cosmetic Storereportable segment | revenue | 2023-05-01 → 2024-01-31 | ¥22.9bn |
| jpcrp040300-q3r_E04896-000Drug And Cosmetic Storereportable segment | revenue external | 2023-05-01 → 2024-01-31 | ¥22.9bn |
| jpcrp040300-q3r_E04896-000Drug And Cosmetic Storereportable segment | segment ordinary income | 2023-05-01 → 2024-01-31 | ¥2.2bn |
| —segment total | revenue | 2023-05-01 → 2024-01-31 | ¥296.4bn |
| —segment total | revenue external | 2023-05-01 → 2024-01-31 | ¥296.4bn |
| —segment total | revenue intersegment | 2023-05-01 → 2024-01-31 | ¥37m |
| —segment total | segment ordinary income | 2023-05-01 → 2024-01-31 | ¥21.9bn |
| Otherother segments | revenue | 2022-05-01 → 2023-01-31 | ¥8.7bn |
| Otherother segments | revenue external | 2022-05-01 → 2023-01-31 | ¥8.7bn |
| Otherother segments | revenue intersegment | 2022-05-01 → 2023-01-31 | ¥43m |
| Otherother segments | segment ordinary income | 2022-05-01 → 2023-01-31 | −¥2m |
| Reconciling Itemsreconciling | revenue | 2022-05-01 → 2023-01-31 | −¥43m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-05-01 → 2023-01-31 | −¥43m |
| Reconciling Itemsreconciling | segment ordinary income | 2022-05-01 → 2023-01-31 | −¥6.4bn |
| jpcrp040300-q3r_E04896-000Dispensing Pharmacyreportable segment | revenue | 2022-05-01 → 2023-01-31 | ¥236.4bn |
| jpcrp040300-q3r_E04896-000Dispensing Pharmacyreportable segment | revenue external | 2022-05-01 → 2023-01-31 | ¥236.4bn |
| jpcrp040300-q3r_E04896-000Dispensing Pharmacyreportable segment | segment ordinary income | 2022-05-01 → 2023-01-31 | ¥18.0bn |
| jpcrp040300-q3r_E04896-000Drug And Cosmetic Storereportable segment | revenue | 2022-05-01 → 2023-01-31 | ¥18.8bn |
| jpcrp040300-q3r_E04896-000Drug And Cosmetic Storereportable segment | revenue external | 2022-05-01 → 2023-01-31 | ¥18.8bn |
| jpcrp040300-q3r_E04896-000Drug And Cosmetic Storereportable segment | segment ordinary income | 2022-05-01 → 2023-01-31 | ¥737m |
| —segment total | revenue | 2022-05-01 → 2023-01-31 | ¥263.9bn |
| —segment total | revenue external | 2022-05-01 → 2023-01-31 | ¥263.9bn |
| —segment total | revenue intersegment | 2022-05-01 → 2023-01-31 | ¥43m |
| —segment total | segment ordinary income | 2022-05-01 → 2023-01-31 | ¥18.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 375
| Item | Context | Value | Unit |
|---|---|---|---|
| Noncurrent assets | Prior1YearInstant | 133444000000 | JPY |
| Noncurrent assets | CurrentQuarterInstant | 136850000000 | JPY |
| Assets | Prior1YearInstant | 231750000000 | JPY |
| Assets | CurrentQuarterInstant | 243688000000 | JPY |
| Accounts payable trade | Prior1YearInstant | 58698000000 | JPY |
| Accounts payable trade | CurrentQuarterInstant | 67987000000 | JPY |
| Short term loans payable | Prior1YearInstant | 3670000000 | JPY |
| Short term loans payable | CurrentQuarterInstant | 3183000000 | JPY |
| Income taxes payable | Prior1YearInstant | 3328000000 | JPY |
| Income taxes payable | CurrentQuarterInstant | 3144000000 | JPY |
| Deposits received | Prior1YearInstant | 18232000000 | JPY |
| Deposits received | CurrentQuarterInstant | 19772000000 | JPY |
| Provision for bonuses | Prior1YearInstant | 3215000000 | JPY |
| Provision for bonuses | CurrentQuarterInstant | 1560000000 | JPY |
| Provision for directors bonuses | Prior1YearInstant | 22000000 | JPY |
| Provision for directors bonuses | CurrentQuarterInstant | 10000000 | JPY |
| Contract liabilities | Prior1YearInstant | 532000000 | JPY |
| Contract liabilities | CurrentQuarterInstant | 450000000 | JPY |
| Other cl | Prior1YearInstant | 5284000000 | JPY |
| Other cl | CurrentQuarterInstant | 4739000000 | JPY |
| Current liabilities | Prior1YearInstant | 92986000000 | JPY |
| Current liabilities | CurrentQuarterInstant | 100847000000 | JPY |
| Long term loans payable | Prior1YearInstant | 5021000000 | JPY |
| Long term loans payable | CurrentQuarterInstant | 2366000000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 4498000000 | JPY |
| Net defined benefit liability | CurrentQuarterInstant | 4815000000 | JPY |
| Other ncl | Prior1YearInstant | 2697000000 | JPY |
| Other ncl | CurrentQuarterInstant | 2378000000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 12218000000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 9561000000 | JPY |
| Liabilities | Prior1YearInstant | 105204000000 | JPY |
| Liabilities | CurrentQuarterInstant | 110409000000 | JPY |
| Capital stock | Prior1YearInstant | 21894000000 | JPY |
| Capital stock | CurrentQuarterInstant | 21894000000 | JPY |
| Capital surplus | Prior1YearInstant | 20504000000 | JPY |
| Capital surplus | CurrentQuarterInstant | 20499000000 | JPY |
| Retained earnings | Prior1YearInstant | 85963000000 | JPY |
| Retained earnings | CurrentQuarterInstant | 92586000000 | JPY |
| Treasury stock | Prior1YearInstant | -2000000000 | JPY |
| Treasury stock | CurrentQuarterInstant | -1983000000 | JPY |
| Shareholders equity | Prior1YearInstant | 126362000000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 132997000000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | -7000000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 137000000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | 95000000 | JPY |
| Remeasurements of defined benefit plans | CurrentQuarterInstant | 72000000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 87000000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 209000000 | JPY |
| Non controlling interests | Prior1YearInstant | 96000000 | JPY |
| Non controlling interests | CurrentQuarterInstant | 71000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |